Study of Ravulizumab in Pediatric Participants With HSCT-TMA
Clinical trial NCT04557735 · COMPLETED
Trial details
- NCT number
- NCT04557735
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2024-11-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.